| Literature DB >> 34422439 |
Cheryl Gatot1, Evan Shern-En Tan1, Ming Han Lincoln Liow1, Jerry Yongqiang Chen1, Meng Ai Png1, Mann Hong Tan1, Tet Sen Howe1, Joyce Suang Bee Koh1.
Abstract
INTRODUCTION: The associated mortality and morbidity in hip fracture patients pose a major healthcare burden for ageing populations worldwide. We aim to analyse how an individual's comorbidity profile based on age-adjusted Charlson Comorbidity Index (CCI) may impact on functional outcomes and 90-day readmission rates after hip fracture surgery.Entities:
Keywords: 90-days readmission; EQ-5D; SF-36; charlson comorbidity index; hip fracture; parker mobility score
Year: 2021 PMID: 34422439 PMCID: PMC8371729 DOI: 10.1177/21514593211036252
Source DB: PubMed Journal: Geriatr Orthop Surg Rehabil ISSN: 2151-4585
Patient Demographics, Clinical Data Summary and Analysis of CCI Scores With 90-Day Readmission Rates.The table above summarises the clinical data used in this study, indicating the patient demographics in each CCI score category, the type of fractures and the results of the univariate analyses looking into 90-day readmissions.
| CCI 0-3 (n = 133) | CCI 4–5 (n = 188) | CCI ≥ 6 (n = 123) | ||
| Gender | .468 | |||
| Male | 38 (28.6%) | 49 (26.1%) | 40 (32.5%) | |
| Female | 95 (71.4%) | 139 (73.9%) | 83 (67.5%) | |
| Fracture type | .716 | |||
| Neck of femur | 86 (64.7%) | 113 (60.1%) | 81 (65.9%) | |
| Intertrochanteric | 44 (33.0%) | 72 (38.3%) | 41 (33.3%) | |
| Subtrochanteric | 3 (2.3%) | 3 (1.6%) | 1 (.8%) | |
| Length of stay (days) | 18 ± 2 | 20 ± 1 | 22 ± 1 | .208 |
| 90-day readmission | 12 (9.0%) | 31 (16.5%) | 31 (25.2%) | .002 |
Analysis of CCI Scores With Functional Outcomes Assessments at Baseline, 3 Months, 6 Months and 12 Months and the relative functional gain. The table above summarises functional outcome scores within each CCI score category. Functional outcomes include the Parker Mobility Score (PMS), EuroQol-5D (EQ-5D), as well as Physical and Mental Component Scores (PCS and MCS, respectively) of Short Form-36.
| CCI 0-3 (n = 133) | CCI 4-5 (n = 188) | CCI ≥ 6 (n = 123) | ||
| PMS | ||||
| Pre-injury | 7.69 ± .19 | 6.54 ± .18 | 5.80 ± .24 | <.001 |
| 3 months | 5.80 ± .23 | 3.80 ± .19 | 3.00 ± .18 | <.001 |
| 6 months | 5.89 ± .23 | 4.39 ± .18 | 3.42 ± .20 | <.001 |
| 12 months | 6.48 ± .22 | 4.72 ± .20 | 3.77 ± .22 | <.001 |
| Change at 12 months vs pre-injury | −1.21 ± .19 | −1.82 ± .17 | −2.03 ± .23 | .016 |
| EQ-5D | ||||
| Pre-injury | .808 ± .024 | .785 ± .019 | .709 ± .029 | .012 |
| 3 months | .615 ± .024 | .501 ± .025 | .411 ± .028 | <.001 |
| 6 months | .676 ± .025 | .598 ± .025 | .492 ± .030 | <.001 |
| 12 months | .718 ± .025 | .612 ± .026 | .503 ± .032 | <.001 |
| Change at 12 months vs pre-injury | −.090 ± .029 | −.173 ± .024 | −.206 ± .036 | .023 |
| PCS | ||||
| Pre-injury | 68.8 ± 2.2 | 52.2 ± 2.1 | 44.0 ± 2.7 | <.001 |
| 3 months | 40.3 ± 2.4 | 27.3 ± 2.0 | 19.3 ± 2.0 | <.001 |
| 6 months | 48.8 ± 2.5 | 35.1 ± 2.1 | 22.6 ± 2.2 | <.001 |
| 12 months | 54.5 ± 2.6 | 35.9 ± 2.2 | 25.2 ± 2.3 | <.001 |
| Change at 12 months vs pre-injury | −14.3 ± 2.1 | −16.3 ± 1.9 | −18.8 ± 2.6 | .373 |
| MCS | ||||
| Pre-injury | 85.7 ± 1.1 | 85.5 ± 0.9 | 83.1 ± 1.5 | .246 |
| 3 months | 82.9 ± 1.4 | 81.6 ± 1.3 | 79.7 ± 1.9 | .361 |
| 6 months | 85.9 ± 1.3 | 82.7 ± 1.3 | 80.9 ± 1.8 | .061 |
| 12 months | 83.3 ± 1.4 | 83.1 ± 1.2 | 79.4 ± 1.8 | .122 |
| Change at 12 months vs pre-injury | −2.4 ± 1.4 | −2.4 ± 1.3 | −3.7 ± 1.9 | .796 |
Analysis of 90-Day Readmission With Functional Scores. Functional outcomes include the Short Form-36 Physical Component Scores (SF-36 PCS), EuroQol-5D (EQ-5D) and Parker Mobility Score (PMS).
| No-readmissions (n = 370) | Readmissions (n = 74) | ||
|---|---|---|---|
| SF-36 PCS | |||
| 3 months | 32 ± 28 | 14 ± 15 | <.05 |
| 6 months | 39 ± 20 | 20 ± 22 | <.05 |
| 12 months | 41 ± 30 | 23 ± 26 | <.05 |
| EQ | |||
| 3 months | .5 ± 0.3 | .3 ± 0.3 | <.05 |
| 6 months | .6 ± 0.3 | .4 ± 0.4 | <.05 |
| 12 months | .6 ± 0.3 | .5 ± 0.4 | <.05 |
| PMS | |||
| 3 months | 4.3 ± 2.6 | 2.5 ± 1.8 | <.05 |
| 6 months | 4.9 ± 2.6 | 3.2 ± 2.1 | <.05 |
| 12 months | 5.2 ± 2.8 | 3.8 ± 2.6 | <.05 |
Multivariate Analysis of SF-36 Physical Component Summary (PCS) Scores. 90-day Readmission Rates and CCI Categorical Groups were Included in the Multivariate Analysis of SF-36 PCS. Reference Group: CCI = 0–3.
| 3 months SF-36 PCS | ||||
|---|---|---|---|---|
| Variable | Exp(B) | Odds ratio (95% CI) | ||
| Lower | Upper | |||
| 90-day readmission | −14.8 | −21.2 | −8.3 | <.05 |
| CCI = 4–5 | −11.97 | −17.7 | −6.27 | <.05 |
| CCI ≥ 6 | −18.7 | −25.04 | −12.3 | <.05 |
| 6 months SF-36 PCS | ||||
| Odds ratio (95% CI) | ||||
| Variable | Exp(B) | Lower | Upper | |
| 90-day readmission | −15.3 | −22.0 | −8.5 | <.05 |
| CCI = 4–5 | −12.6 | −18.5 | −6.65 | <.05 |
| CCI ≥ 6 | −23.7 | −30.3 | −17.1 | <.05 |
| 12 months SF-36 PCS | ||||
| Odds ratio (95% CI) | ||||
| Variable | Exp(B) | Lower | Upper | Upper |
| 90-day readmission | −13.8 | −20.96 | −6.64 | <.05 |
| CCI = 4–5 | −17.6 | −23.9 | −11.2 | <.05 |
| CCI ≥ 6 | −27.1 | −34.1 | −20.1 | <.05 |
Multivariate Analysis of EuroQol-5D (EQ-5D). 90-day Readmission Rates and CCI Categorical Groups were Included in the Multivariate Analysis of EQ-5D. Reference group: CCI = 0–3.
| 3 months EQ-5D | ||||
|---|---|---|---|---|
| Variable | Exp(B) | Odds ratio (95% CI) | ||
| Lower | Upper | |||
| 90-day readmission | −.184 | −.262 | −.107 | <.05 |
| CCI = 4–5 | −.100 | −.169 | −.032 | .004 |
| CCI > 6 | −.175 | −.251 | −.098 | <.05 |
| 6 months EQ-5D | ||||
| Odds ratio (95% CI) | ||||
| Variable | Exp(B) | Lower | Upper | |
| 90-day readmission | −.232 | − .311 | − .153 | <.05 |
| CCI = 4–5 | − .60 | −.130 | .009 | .09 |
| CCI > 6 | − .146 | −.224 | −.068 | <.05 |
| 12 months EQ-5D | ||||
| Odds ratio (95% CI) | ||||
| Variable | Exp(B) | Lower | Upper | |
| 90-day readmission | −.163 | −.247 | −.079 | <.05 |
| CCI = 4–5 | −.094 | −.168 | −.020 | .013 |
| CCI > 6 | −.189 | −.271 | −.106 | <.05 |
* statistically significant
Multivariate Analysis of Parker Mobility Scores (PMS). 90-day Readmission Rates and CCI Categorical Groups were Included in the Multivariate Analysis of PMS. Reference group: CCI = 0–3.
| 3 months PMS | ||||
|---|---|---|---|---|
| Variable | Exp(B) | Odds ratio (95% CI) | ||
| Lower | Upper | |||
| 90-day readmission | −1.437 | −2.038 | −.836 | <.05 |
| CCI = 4–5 | −1.178 | −1.707 | −.648 | <.05 |
| CCI > 6 | −1.866 | −2.46 | −1.24 | <.05 |
| 6 months PMS | ||||
| Odds ratio (95% CI) | ||||
| Variable | Exp(B) | Lower | Upper | |
| 90-day readmission | −1.265 | −1.879 | −.650 | <.05 |
| CCI = 4–5 | −1.412 | −1.953 | −.871 | <.05 |
| CCI > 6 | −2.267 | −2.871 | −1.664 | <.05 |
| 12 months PMS | ||||
| Odds ratio (95% CI) | ||||
| Variable | Exp(B) | Lower | Upper | |
| 90-day readmission | −1.003 | −1.653 | −.352 | .003 |
| CCI = 4–5 | −1.683 | −2.256 | −1.110 | <.05 |
| CCI ≥ 6 | −2.547 | −3.186 | −1.908 | <.05 |